Literature DB >> 34853212

Association between Serum Uric Acid and Impaired Endothelial Function: The Circulatory Risk in Communities Study.

Jingyun Tang1, Keyang Liu1, Ehab S Eshak1,2, Renzhe Cui3, Ryoto Sakaniwa1, Hironori Imano1, Jia-Yi Dong1, Hiroyasu Iso1.   

Abstract

AIMS: Higher serum uric acid (UA) may impair endothelial function. However, population-based evidence examining the association between serum UA levels and endothelial function remains to be limited. Thus, in this study, we aimed to investigate this in the general population.
METHODS: In this cross-sectional study, 1000 participants (496 males and 504 females), aged 30-79 years, free from a history of gout, have undergone both serum UA and brachial artery flow-mediated dilation (FMD) measurements. Participants were divided into four groups based on serum UA quartiles. Logistic regression models were used to calculate odds ratios (ORs) for low FMD according to the serum UA levels.
RESULTS: In total, 203 participants (138 males and 65 females) with %FMD ≤ 5.0% were identified to have endothelial dysfunction. The multivariable OR of low FMD for highest quartiles vs. lowest quartiles was 2.39 (95% confidence interval [CI]: 1.32-4.34), while OR per 1-standard deviation (SD) increment was 1.28 (95% CI: 1.04-1.56). The positive association was noted to be more evident in females (OR per 1-SD increment: 1.46; 95% CI: 1.08-1.96) than in males and confined to individuals not using antihypertensive medications. The ORs per 1-SD increment were 1.01 (95% CI: 0.68-1.50) among individuals using antihypertensive medications and 1.43 (95% CI: 1.12-1.81) among individuals not using antihypertensive medications.
CONCLUSION: Higher serum UA was positively associated with the prevalence of endothelial dysfunction in samples of the general Japanese population and that positive association was confined to individuals not using antihypertensive medications.

Entities:  

Keywords:  Cross-sectional study; Endothelial dysfunction; Flow-mediated dilation; Japanese; Uric acid

Mesh:

Substances:

Year:  2021        PMID: 34853212      PMCID: PMC9529376          DOI: 10.5551/jat.63199

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.394


  44 in total

1.  Correlations between brachial endothelial function and cardiovascular risk factors: a survey of 2,511 Chinese subjects.

Authors:  Ping-Ting Yang; Hong Yuan; Ya-Qin Wang; Xia Cao; Liu-Xin Wu; Zhi-Heng Chen
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Genetic impact on uric acid concentration and hyperuricemia in the Japanese population.

Authors:  Fumihiko Takeuchi; Ken Yamamoto; Masato Isono; Tomohiro Katsuya; Koichi Akiyama; Keizo Ohnaka; Hiromi Rakugi; Yukio Yamori; Toshio Ogihara; Ryoichi Takayanagi; Norihiro Kato
Journal:  J Atheroscler Thromb       Date:  2012-12-13       Impact factor: 4.928

3.  Elevated serum uric acid is associated with peripheral endothelial dysfunction in women.

Authors:  Riad Taher; Jaskanwal D Sara; Megha Prasad; Nikhil Kolluri; Takumi Toya; Lilach O Lerman; Amir Lerman
Journal:  Atherosclerosis       Date:  2019-07-17       Impact factor: 5.162

4.  Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study.

Authors:  Mervi Oikonen; Maria Wendelin-Saarenhovi; Leo-Pekka Lyytikäinen; Niina Siitonen; Britt-Marie Loo; Antti Jula; Ilkka Seppälä; Liisa Saarikoski; Terho Lehtimäki; Nina Hutri-Kähönen; Markus Juonala; Mika Kähönen; Risto Huupponen; Jorma S A Viikari; Olli T Raitakari
Journal:  Atherosclerosis       Date:  2012-06-07       Impact factor: 5.162

5.  Elevated serum uric acid levels are associated with endothelial dysfunction in HIV patients receiving highly-active antiretroviral therapy.

Authors:  Matteo Pirro; Vanessa Bianconi; Elisabetta Schiaroli; Daniela Francisci; Massimo R Mannarino; Francesco Bagaglia; Amirhossein Sahebkar; Tony Merriman; Franco Baldelli
Journal:  Atherosclerosis       Date:  2018-03-17       Impact factor: 5.162

6.  Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults.

Authors:  D Erdogan; H Gullu; M Caliskan; E Yildirim; M Bilgi; T Ulus; N Sezgin; H Muderrisoglu
Journal:  Int J Clin Pract       Date:  2005-11       Impact factor: 2.503

Review 7.  Metabolic syndrome, diabetes, and hyperuricemia.

Authors:  Changgui Li; Ming-Chia Hsieh; Shun-Jen Chang
Journal:  Curr Opin Rheumatol       Date:  2013-03       Impact factor: 5.006

8.  Trends for blood pressure and its contribution to stroke incidence in the middle-aged Japanese population: the Circulatory Risk in Communities Study (CIRCS).

Authors:  Hironori Imano; Akihiko Kitamura; Shinichi Sato; Masahiko Kiyama; Tetsuya Ohira; Kazumasa Yamagishi; Hiroyuki Noda; Takeshi Tanigawa; Hiroyasu Iso; Takashi Shimamoto
Journal:  Stroke       Date:  2009-04-02       Impact factor: 7.914

9.  Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study.

Authors:  Hyon K Choi; Lucia Cea Soriano; Yuqing Zhang; Luis A García Rodríguez
Journal:  BMJ       Date:  2012-01-12

10.  Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study.

Authors:  Tatsuya Maruhashi; Junko Soga; Noritaka Fujimura; Naomi Idei; Shinsuke Mikami; Yumiko Iwamoto; Masato Kajikawa; Takeshi Matsumoto; Takayuki Hidaka; Yasuki Kihara; Kazuaki Chayama; Kensuke Noma; Ayumu Nakashima; Chikara Goto; Hirofumi Tomiyama; Bonpei Takase; Akira Yamashina; Yukihito Higashi
Journal:  Heart       Date:  2013-10-23       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.